Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lichang Chen

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Pathogens (Basel, Switzerland)|December 31, 2025
Integrating GPC3 with Other Biomarkers to Improve the Diagnosis of Early-Stage Liver CancerJing Xu, Lin Tan, Ning Jiang, et al.
Journal of Medical Virology|July 4, 2017
Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern ChinaJie Lu, Xiaogang Xiang, Zhujun Cao, et al.
Antiviral Research|August 14, 2021
A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in ChinaPeipei Ren, Hu Li, Yan Huang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 9, 2024
Characterization, hazard identification, and risk assessment of volatile organic compounds in Poly(butylene adipate-co-terephthalate)-based food contact articlesHanke Li, Hongjian Miao, Lichang Chen, et al.
Ecotoxicology and Environmental Safety|March 11, 2023
Potential causal links between long-term ambient particulate matter exposure and cardiovascular mortality: New evidence from a large community-based cohort in South ChinaYuqin Zhang, Ying Wang, Zhicheng Du, et al.
Theranostics|August 22, 2018
Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injuryRuidong Mo, Rongtao Lai, Jie Lu, et al.
Expert Opinion on Biological Therapy|September 6, 2018
Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high riskPeipei Ren, Zhujun Cao, Ruidong Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2017
Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infectionZhujun Cao, Ziqiang Li, Hui Wang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Pathogens (Basel, Switzerland)|December 31, 2025
Integrating GPC3 with Other Biomarkers to Improve the Diagnosis of Early-Stage Liver CancerJing Xu, Lin Tan, Ning Jiang, et al.
Journal of Medical Virology|July 4, 2017
Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern ChinaJie Lu, Xiaogang Xiang, Zhujun Cao, et al.
Antiviral Research|August 14, 2021
A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in ChinaPeipei Ren, Hu Li, Yan Huang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 9, 2024
Characterization, hazard identification, and risk assessment of volatile organic compounds in Poly(butylene adipate-co-terephthalate)-based food contact articlesHanke Li, Hongjian Miao, Lichang Chen, et al.
Ecotoxicology and Environmental Safety|March 11, 2023
Potential causal links between long-term ambient particulate matter exposure and cardiovascular mortality: New evidence from a large community-based cohort in South ChinaYuqin Zhang, Ying Wang, Zhicheng Du, et al.
Theranostics|August 22, 2018
Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injuryRuidong Mo, Rongtao Lai, Jie Lu, et al.
Expert Opinion on Biological Therapy|September 6, 2018
Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high riskPeipei Ren, Zhujun Cao, Ruidong Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2017
Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infectionZhujun Cao, Ziqiang Li, Hui Wang, et al.
Pageof 4